Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway-Reference-Cited by-同舟云学术

Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway

Published:2020-08 Issue: Volume:128 Page:110286
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chen Manman,Xing Jingwei,Pan Danqing,Peng Xiuhua,Gao Pengfei

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference59 articles.

1. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference;Neuschwander-Tetri;Hepatology,2003

2. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study;Williams;Gastroenterology.,2011

3. Nonalcoholic fatty liver disease: diagnostic, symptoms, treatment. Guidelines were approved by the xv gastroenterological scientific society of Russia in 2015;Lazebnik;Eksp Klin Gastroenterol,2015

4. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology.,2016

5. Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease;Ban;Int J Mol Sci.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCL6 promotes the progression of NAFLD through regulation of PPARα;Cytokine;2024-02

2. Hepatoprotective efficacy and interventional mechanism of the panaxadiol saponin component in high-fat diet-induced NAFLD mice;Food & Function;2024

3. A narrative review on the role of hesperidin on metabolic parameters, liver enzymes, and inflammatory markers in nonalcoholic fatty liver disease;Food Science & Nutrition;2023-10-08

4. CXCL6: A potential therapeutic target for inflammation and cancer;Clinical and Experimental Medicine;2023-08-23

5. A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease;Reviews in Endocrine and Metabolic Disorders;2023-03-31